Pegylated-interferon-αα_2a in clinical practice: how to manage patients suffering from side effects

By Calvaruso Vincenza   Mazza Marta   Almasio Piero L  

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 429-435

Informa Healthcare

Access to resources Recommend Favorite

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice

By Bruce R Douglas   Moody David E   Altice Frederick L   Gourevitch Marc N   Friedland Gerald H  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 3, 2013-05 ,pp. : 249-269

Informa Healthcare

Access to resources Recommend Favorite

How to Assess Sympathetic Nervous System Activity in Clinical Practice

By  

Current Clinical Pharmacology, Vol. 8, Iss. 3, 2013-01 ,pp. : 182-188

Bentham Science Publishers

Access to resources Recommend Favorite

Ability of older people with dementia or cognitive impairment to manage medicine regimens: a narrative review

By  

Current Clinical Pharmacology, Vol. 10, Iss. 3, 2015-01 ,pp. : 213-221

Bentham Science Publishers

Access to resources Recommend Favorite

Patients and Clinical Practice Guidelines Development

By Winn Rodger J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 6, 2004-11 ,pp. : 521-525

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite